Safety and Immune Response Study of An Intranasal COVID-19 Booster Vaccine

Go Back to All Clinical Trials

Safety and Immune Response Study of An Intranasal COVID-19 Booster Vaccine

Brief description of study

The NYU Langone Vaccine Center Long Island site is enrolling adult volunteers, aged 18-64, for a clinical trial evaluating a new investigational NIH-DMID intranasal COVID-19 booster vaccine.

If you are eligible and decide to participate, you may be asked to complete 9-in person clinic visits at the Vaccine Center-Long Island site, as well as 1 phone call, over one year.

You will be compensated $90 for screening visit, $135 for vaccination visit, and $110 for most follow-up visits.

Clinical Study Identifier: s24-00402

ClinicalTrials.gov Identifier: NCT06441968

Principal Investigator: Mark J. Mulligan.

Other Investigators: Dinuli Hashangani Delpachitra, Andrew Banks Fleming, Asif Noor, Martin Backer.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies